What eye drops are recommended for a patient with an eye complaint?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a patient with an eye complaint, the recommended eye drops are antihistamine drops such as ketotifen (Zaditor, Alaway) or olopatadine (Pataday) for allergic conjunctivitis, typically used twice daily 1. When considering the treatment of eye complaints, it's essential to identify the underlying condition to provide the most effective care.

  • For dry eyes, artificial tears like Systane, Refresh, or TheraTears can be used as needed throughout the day 1.
  • For allergic conjunctivitis, antihistamine drops such as ketotifen (Zaditor, Alaway) or olopatadine (Pataday) can provide relief, typically used twice daily 1.
  • Bacterial conjunctivitis may require antibiotic drops like polymyxin B-trimethoprim (Polytrim) or moxifloxacin (Vigamox), usually administered 4 times daily for 5-7 days.
  • For glaucoma, prescription drops such as timolol, latanoprost, or brimonidine help reduce intraocular pressure, with specific dosing determined by an eye care professional.
  • Red, irritated eyes might benefit from redness-relieving drops containing tetrahydrozoline (Visine) or naphazoline, though these should not be used for more than 2-3 days to avoid rebound redness. It's crucial to seek professional evaluation before self-treating eye conditions, as improper treatment may worsen the condition or delay necessary care 1. Always wash hands before applying eye drops, and avoid touching the dropper tip to prevent contamination. In cases of severe eye complaints, such as dupilumab-related ocular surface disorders, preservative-free ocular lubricants and topical antihistamine eyedrops may be recommended as first-line and second-line treatments, respectively 1.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION Instill one drop in the affected eye 3 times a day for 7 days. FOR TOPICAL OPHTHALMIC USE ONLY. Now OTC! ANTIHISTAMINE EYE DROPS UPTO 12 HOURS EYE ITCH RELIEF

Recommended Eye Drops:

  • moxifloxacin (OPHTH) 2
  • ketotifen (OPHTH) 3 Key Points:
  • Use as directed by a physician
  • Follow the recommended dosage and administration instructions
  • For topical ophthalmic use only
  • Do not touch the dropper tip to any surface to avoid contamination

From the Research

Eye Drops for Patient with Eye Complaint

  • For a patient with dry eye disease, loteprednol etabonate ophthalmic suspension 0.5% or 0.25% can be used as an effective treatment option 4
  • Cyclosporine formulations, such as RESTASIS, VEVYE, and CEQUA, are also FDA-approved for the treatment of dry eye disease 5
  • Other treatment options for dry eye disease include XIIDRA (lifitegrast), EYSUVIS (loteprednol etabonate ophthalmic suspension 0.25%), and MIEBO (perfluorohexyloctane ophthalmic solution) 5
  • For patients with allergic conjunctivitis, treatment options may include anti-inflammatory or anti-allergic eye drops, although specific drops are not mentioned in the provided studies

Considerations for Eye Complaints

  • It is essential to determine the underlying cause of the eye complaint to provide appropriate treatment 6
  • Patients with persistent or severe conditions should be referred to an ophthalmologist for further evaluation and treatment 6
  • Some patients may experience overlap of symptoms between allergic conjunctivitis and dry eye syndrome, and treatment should be tailored accordingly 7

Emerging Therapies

  • Several emerging therapies are being studied for the treatment of dry eye disease and allergic conjunctivitis, including novel molecules and new delivery systems 8, 5
  • These emerging therapies aim to target the underlying immunopathophysiology of the conditions and provide more effective treatment options 8, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Loteprednol Etabonate for the Treatment of Dry Eye Disease.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2020

Research

Quintessence of currently approved and upcoming treatments for dry eye disease.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2024

Research

Allergic conjunctivitis and dry eye syndrome.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2012

Research

Emerging therapies in allergic conjunctivitis and dry eye syndrome.

Expert opinion on pharmacotherapy, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.